CTLA-4 +49A>G Polymorphism Is Associated with Advanced Non-Small Cell Lung Cancer Prognosis

Association between the Cytotoxic T-Lymphocyte Antigen 4 +49G > A polymorphism and cancer risk: a meta-analysis

(2010) Jian Zheng et al.   BMC CANCER

Combination Therapy of Established Tumors by Antibodies Targeting Immune Activating and Suppressing Molecules

(2010) K. Takeda et al.   JOURNAL OF IMMUNOLOGY

+49G > A polymorphism in the cytotoxic T-lymphocyte antigen-4 gene increases susceptibility to hepatitis B-related hepatocellular carcinoma in a male Chinese population

(2009) Xing Gu et al.   HUMAN IMMUNOLOGY

CTLA-4 +49A>G polymorphism is associated with the risk but not with the progression of colorectal cancer in Chinese

(2009) Peng Qi et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Functional polymorphism ofcytotoxic T-lymphocyte antigen 4and nasopharyngeal carcinoma susceptibility in a Chinese population

(2009) M. Xiao et al.   International Journal of Immunogenetics

Influence of Cytotoxic T Lymphocyte-associated Antigen 4 (CTLA4) Common Polymorphisms on Outcome in Treatment of Melanoma Patients With CTLA-4 Blockade

(2009) Willemijn B. Breunis et al.   JOURNAL OF IMMUNOTHERAPY

Association of Cytotoxic T Lymphocyte-associated antigen-4 gene haplotype with the susceptibility to gastric cancer

(2009) Ruiping Hou et al.   MOLECULAR BIOLOGY REPORTS

Impact of FDG-PET-Induced Treatment Choices on Long-Term Outcome in Non-Small Cell Lung Cancer

(2009) Isabelle Wauters et al.   RESPIRATION

Functional Genetic Variations in Cytotoxic T-Lymphocyte Antigen 4 and Susceptibility to Multiple Types of Cancer

(2008) T. Sun et al.   CANCER RESEARCH

Investigation ofCTLA-4andCD28gene polymorphisms in a group of Turkish patients with colorectal cancer

(2008) F. Dilmec et al.   International Journal of Immunogenetics

The Mechanism of Anti-CTLA-4 Activity and the Negative Regulation of T-Cell Activation

(2008) J. D. Wolchok et al.   ONCOLOGIST

MDR1 Single Nucleotide Polymorphism G2677T/A and Haplotype Are Correlated with Response to Docetaxel-Cisplatin Chemotherapy in Patients with Non-Small-Cell Lung Cancer

(2008) Ji-hong Pan et al.   RESPIRATION